Applying Multiple Criteria Decision Analysis (MCDA) in the context of HTA: an experimental case study on metastatic colorectal cancer

Applying Multiple Criteria Decision Analysis (MCDA) in the context of HTA: an experimental case study on metastatic colorectal cancer

Bibliographic Details
Main Authors:	Aris Angelis, Panos Kanavos
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2015-12-01
Series:	Journal of Pharmaceutical Policy and Practice
Subjects:	Metastatic Colorectal Cancer Health Technology Assessment Methodological Framework Stakeholder Engagement Resource Allocation Decision
Online Access:	https://www.tandfonline.com/doi/10.1186/2052-3211-8-S1-O8

Similar Items

Using Multiple Criteria Decision Analysis (MCDA) to make coverage decisions: a methodological framework
by: Panos Kanavos, et al.
Published: (2015-12-01)

CLINICAL EXPERIENCE OF COMBINED AVASTIN THERAPY IN METASTATIC COLORECTAL CANCER
by: V. A. Ekimov
Published: (2015-02-01)

High Concordance of Genomic Profiles between Primary and Metastatic Colorectal Cancer
by: Seung Eun Lee, et al.
Published: (2021-05-01)

CLINICAL EXPERIENCE OF PROLONGED AVASTIN THERAPY IN METASTATIC COLORECTAL CANCER
by: A. F. Saidullaeva
Published: (2015-02-01)

CLINICAL EXPERIENCE OF PROLONGED BEVACIZUMAB THERAPY IN METASTATIC COLORECTAL CANCER
by: I. S. Bulavina, et al.
Published: (2015-02-01)

Sociodemographic and clinical factors associated with receipt of biomarker testing in patients with metastatic colorectal cancer
by: Sarah C. Markt, et al.
Published: (2023-01-01)

SHORT-TERM RESULTS OF SIMULTANEOUS SURGERIES AT METASTATIC COLORECTAL CANCER
by: A. S. Zagaynov, et al.
Published: (2017-02-01)

The Effect Of Chemotherapy On Malnutrition In Geriatric Group With Metastatic Colorectal Cancer
by: Esat Namal
Published: (2019-01-01)

Expert consensus on maintenance treatment for metastatic colorectal cancer in China
by: Rui-Hua Xu, et al.
Published: (2016-01-01)

Kras in metastatic colorectal cancer
by: A Wicki, et al.
Published: (2010-11-01)

Comparison of Carcinoembryonic Antigen Level and E-Cadherin Expression between Metastatic and Non-Metastatic Colorectal Carcinoma in RSUP, Dr. Sardjito Yogyakarta-Indonesia
by: Rianto Prabowo, et al.
Published: (2023-10-01)

Metastatic Colorectal Cancer. First Line Therapy for Unresectable Disease
by: Jorge Aparicio, et al.
Published: (2020-11-01)

THE HIGH ACTIVITY OF VECTIBIX IN PATIENTS WITH METASTATIC COLORECTAL CANCER WITH THE RAS WILD-TYPE GENE
by: N. N. Semenov
Published: (2015-02-01)

The Impact of Bevacizumab and Chemotherapy on Quality of Life in Metastatic Colorectal Cancer Patients
by: Diana Cornelia Moisuc, et al.
Published: (2023-02-01)

Second-line targeted therapy for metastatic colorectal cancer. Possibilities for choices
by: L. V. Bolotina, et al.
Published: (2018-11-01)

An Unconventional Regimen of Carboplatin and Paclitaxel in Metastatic Colorectal Carcinosarcoma: A Case Report and Review of Literature
by: Changsu Lawrence Park, et al.
Published: (2023-05-01)

Brazilian cohort results of the PRECONNECT study: safety and efficacy of trifluridine/tipiracil in metastatic colorectal cancer
by: Celso Abdon Lopes de Mello, et al.
Published: (2022-12-01)

An Update on the Role of Anti-EGFR in the Treatment of Older Patients with Metastatic Colorectal Cancer
by: Gerardo Rosati, et al.
Published: (2022-11-01)

Drug Holidays and Overall Survival of Patients with Metastatic Colorectal Cancer
by: Silvio Ken Garattini, et al.
Published: (2021-07-01)

Biomarkers in Metastatic Colorectal Cancer: Status Quo and Future Perspective
by: Alberto Puccini, et al.
Published: (2022-10-01)

Current Treatments of Metastatic Colorectal Cancer with Immune Checkpoint Inhibitors—2020 Update
by: Gerhard Jung, et al.
Published: (2020-10-01)

The use of regorafenib in colorectal cancer
by: Marina I Sekacheva, et al.
Published: (2019-06-01)

The Soluble Urokinase-Type Plasminogen Activator Receptor as a Biomarker for Survival and Early Treatment Effect in Metastatic Colorectal Cancer
by: Kristian Blomberg, et al.
Published: (2021-10-01)

Preliminary results of an observational program for estimating the duration of bevacizumab therapy in patients with metastatic colorectal cancer in daily clinical practice
by: I V Poddubnaya, et al.
Published: (2013-03-01)

Molecular-Biology-Driven Treatment for Metastatic Colorectal Cancer
by: Eleonora Lai, et al.
Published: (2020-05-01)

Biomarker-Guided Anti-EGFR Rechallenge Therapy in Metastatic Colorectal Cancer
by: Davide Ciardiello, et al.
Published: (2021-04-01)

NEW POSSIBILITIES OF THERAPY OF INTENSIVELY PRETREATED METASTATIC COLORECTAL CANCER PATIENTS
by: E. V. ARTAMONOVA
Published: (2016-12-01)

Pharmacoeconomic-guided choice of systemic chemotherapy in metastatic colorectal cancer patients
by: M. Yu. Fedyanin, et al.
Published: (2017-09-01)

Graphene Oxide and Fluorescent-Aptamer-Based Novel Aptasensors for Detection of Metastatic Colorectal Cancer Cells
by: Hang Chen, et al.
Published: (2022-07-01)

Diabetes Mellitus and Other Predictors for the Successful Treatment of Metastatic Colorectal Cancer: A Retrospective Study
by: Deiana Roman, et al.
Published: (2022-06-01)

Artificial-Intelligence-Assisted Detection of Metastatic Colorectal Cancer Cells in Ascitic Fluid
by: Hyung Kyung Kim, et al.
Published: (2024-03-01)

Lessons to Learn for Adequate Targeted Therapy Development in Metastatic Colorectal Cancer Patients
by: Helena Oliveres, et al.
Published: (2021-05-01)

Prognostic Value of Sarcopenia in Metastatic Colorectal Cancer Patients Treated with Trifluridine/Tipiracil
by: Mateusz Malik, et al.
Published: (2021-10-01)

Antiangiogenic Drug-Induced Proteinuria as a Prognostic Factor in Metastatic Colorectal Cancer
by: Diana Cornelia Moisuc, et al.
Published: (2022-05-01)

Construction of a DDR-related signature for predicting of prognosis in metastatic colorectal carcinoma
by: Maohua Wei, et al.
Published: (2023-02-01)

Adapting a conceptual framework to engage diverse stakeholders in genomic/precision medicine research
by: Karriem S. Watson, et al.
Published: (2022-08-01)

A Retrospective Study of Trifluridine/Tipiracil with Fruquintinib in Patients with Chemorefractory Metastatic Colorectal Cancer
by: Jiayun Zou, et al.
Published: (2023-12-01)

METASTATIC COLORECTAL TREATMENT COSTS OF USING TARGETED DRUGS IN SECOND AND FURTHER LINES THERAPY
by: N. A. Avxentyev, et al.
Published: (2016-09-01)

Treatment of patients with metastatic colorectal cancer and poor performance status: current evidence and challenges
by: Lucila Soares da Silva Rocha, et al.
Published: (2018-09-01)

Therapeutic Targeting of the Tumour Microenvironment in Metastatic Colorectal Cancer
by: Rhynelle S. Dmello, et al.
Published: (2021-02-01)